Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B

Hariklia Kranidioti | Spilios Manolakopoulos | George Kontos| Michael S. Breen |
Anastasia Kourikou | Melanie Deutsch| Maria Ester Quesada-Del-Bosque |
Rocio T. Martinez-Nunez | Mohammed M. Naiyer | Christopher H. Woelk |
Tilman Sanchez-Elsner| Emilia Hadziyannis | George Papatheodoridis |
Salim I. Khakoo

Δείτε ΕΔΩ το άρθρο